Resiliency in Results – What We Learn When Trials Are Terminated (September 16, 2020)
by: Parent Project Muscular Dystrophy
On September 16, 2020 PPMD was pleased to be joined by partners at Pfizer Inc., Roche/Genentech, and Wave Life Sciences as they discussed what they have learned from terminated trials, the value of participation, and the influence the Duchenne community has had on their paths forward.
by: Parent Project Muscular Dystrophy
